Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Significant Increase in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 33,100 shares, a growth of 294.0% from the October 15th total of 8,400 shares. Based on an average daily trading volume, of 48,800 shares, the days-to-cover ratio is currently 0.7 days.

Ocean Biomedical Stock Up 46.6 %

OCEAW traded up $0.01 during trading on Tuesday, hitting $0.05. 4,175 shares of the stock traded hands, compared to its average volume of 41,181. The business has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.05. Ocean Biomedical has a twelve month low of $0.02 and a twelve month high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.